Plasma hydroxy‐metronidazole/metronidazole ratio in patients with liver disease and in healthy volunteers.

作者
Marcelo Nicolás Muscará,José Pedrazzoli,EL Miranda,J. G. P. Ferraz,Eduardo Alexandre Hofstätter,G. Leite,A. F. N. Magalhaes,S. Leonardi,Gilberto De Nucci
出处
期刊:British Journal of Clinical Pharmacology [Wiley]
卷期号:40 (5): 477-480 被引量:26
标识
DOI:10.1111/j.1365-2125.1995.tb05792.x
摘要

Metronidazole pharmacokinetics were studied in patients with different degrees of liver cirrhosis, classified according to the Child-Pugh algorithm (A, B or C, as liver disease severity increases) and in schistosomic patients. Metronidazole (500 mg) was administered i.v. as a slow infusion over 20 min, and blood samples were collected at set intervals after the end of the infusion. The plasma concentrations of metronidazole and its main metabolite hydroxy-metronidazole were quantified by reversed-phase h.p.l.c. with u.v. detection. The metronidazole and hydroxy-metronidazole areas under the curve from 0 to 24 h (AUC0,24h), the metronidazole terminal elimination half-life (t1/2), the total clearance (CL), the metronidazole volume of distribution (V) values and the hydroxy-metronidazole/metronidazole concentration ratios as a function of time were calculated for each group. Comparison of the metronidazole AUC0,24h, t1/2 and CL values revealed that metronidazole metabolism is progressively impaired as the severity of liver disease increases. There were no variations in these parameters between the schistosomic and Child-Pugh A groups. In addition, there were no differences in the V and hydroxy-metronidazole AUC0,24h among the various groups studied. However, metronidazole metabolism was delayed in patients with hepatic disease, as illustrated by the hydroxy-metronidazole/metronidazole ratio 10 min after the end of metronidazole infusion. These results indicate that the clinical assessment of liver disease is paralleled by an impairment of metronidazole metabolism. Of the studied variables, we propose the hydroxy-metronidazole/metronidazole ratio 10 min after metronidazole infusion as a suitable and practical index for liver function evaluation.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
兮颜完成签到,获得积分10
1秒前
李健的应助被Aveeva采纳,获得10
3秒前
跳跃文轩完成签到,获得积分10
3秒前
忧虑的凌雪完成签到,获得积分10
4秒前
4秒前
star完成签到,获得积分10
5秒前
哈基米南北绿豆完成签到,获得积分10
5秒前
causl完成签到,获得积分10
5秒前
Reybor完成签到,获得积分10
6秒前
甜甜十三完成签到,获得积分10
6秒前
xiaodu完成签到,获得积分10
6秒前
我忘了李发布了新的文献求助10
8秒前
9秒前
兮颜发布了新的文献求助30
10秒前
10秒前
优秀的小丸子完成签到,获得积分10
11秒前
人间慈悲的应助被胡平采纳,获得10
11秒前
11秒前
11秒前
sun完成签到,获得积分10
12秒前
13秒前
15秒前
15秒前
彭于晏的应助被liuqc采纳,获得10
15秒前
田様的应助被Esther采纳,获得10
15秒前
Jiang完成签到,获得积分10
15秒前
王长长完成签到,获得积分10
16秒前
泡泡123123完成签到,获得积分10
16秒前
Ava的应助被我忘了李采纳,获得10
16秒前
16秒前
蝈蝈崽发布了新的文献求助10
17秒前
阔达的夜山完成签到,获得积分10
17秒前
Hello的应助被hky采纳,获得10
17秒前
KimGyuvin发布了新的文献求助10
18秒前
Menand发布了新的文献求助10
18秒前
平常寒烟发布了新的文献求助10
21秒前
沉默的从安完成签到,获得积分10
21秒前
22秒前
蝈蝈崽完成签到,获得积分10
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186784
求助须知:如何正确求助?哪些是违规求助? 9575092
关于积分的说明 21839541
捐赠科研通 7784418
什么是DOI,文献DOI怎么找? 3434819
关于科研通互助平台的介绍 2559221
邀请新用户注册赠送积分活动 2481682